To help detect, diagnose, and evaluate the severity of congestive heart failure (CHF)
BNP and NT-proBNP
When you have symptoms of heart failure, such as shortness of breath and fatigue, or when you are being treated for CHF
A blood sample drawn from a vein in your arm
None
-
How is it used?
A test for B-type natriuretic peptide (BNP) or N-terminal pro b-type natriuretic peptide (NT-proBNP) is primarily used to help detect, diagnose, and evaluate the severity of heart failure. It can be used, along with other cardiac biomarker tests, to detect heart stress and damage and/or along with lung function tests to distinguish between causes of shortness of breath. Chest X-rays and an ultrasound test called echocardiography may also be performed.
Heart failure can be confused with other conditions, and it may co-exist with them. BNP and NT-proBNP levels can help doctors differentiate between heart failure and other problems, such as lung disease. An accurate diagnosis is important because the treatments are often different and must be started as soon as possible.
Although BNP and NT-proBNP are usually used to recognize heart failure, an increased level in people with acute coronary syndrome (ACS) indicates an increased risk of recurrent events. Thus, a health practitioner may use either BNP or NT-proBNP to evaluate risk of a future cardiac event in someone with ACS.
-
When is it ordered?
A BNP or NT-proBNP test may be ordered in a doctor's office when a person has signs and symptoms that could be due to heart failure. These may include:
- Difficulty breathing, shortness of breath
- Fatigue
- Swelling in the feet, ankles, legs, abdomen
Testing may be done in the emergency room when someone is in crisis and/or has symptoms that could be due to heart failure and health practitioners need to quickly determine if a person is suffering from heart failure or some other medical problem.
Several BNP or NT-proBNP tests may be done over a period of time when an individual is being treated for heart failure to monitor the effects of therapy.
-
What does the test result mean?
Higher-than-normal results suggest that a person has some degree of heart failure, and the level of BNP or NT-proBNP in the blood is related to its severity. Higher levels of BNP or NT-proBNP are often associated with a worse outlook (prognosis) for the person.
Normal results indicate that the person's symptoms are likely due to something other than heart failure.
-
Is there anything else I should know?
BNP and NT-proBNP levels decrease in most people who are taking drug therapies for heart failure, such as angiotensin-converting enzyme (ACE) inhibitors, beta blockers, and diuretics.
Levels of both BNP and NT-proBNP tend to increase with age.
Levels of NT-proBNP and BNP may be increased in persons with kidney disease due to reduced clearance.
While both BNP and NT-proBNP will rise with left ventricle dysfunction and either can be measured for diagnosis or monitoring therapy, they are not interchangeable and the results cannot be directly compared.
-
How common is heart failure?
According to the National Heart, Lung and Blood Institute, about 5.7 million people in the United States are living with heart failure and the number is growing. People who are most at risk are those over 65 years old, African Americans, people who are overweight, those who have diabetes and people who have had a heart attack. Men are more likely than women to develop heart failure.
-
How is heart failure treated?
For information on treatment, read the article on Congestive Heart Failure or visit the American Heart Association's web site.